Cloud-clone
SKU:PAB180Rb51
Polyclonal Antibody to Clusterin (CLU)
Polyclonal Antibody to Clusterin (CLU)
Couldn't load pickup availability
Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.
Product No.
PAB180Rb51
Organism Species
Oryctolagus cuniculus (Rabbit).
Source
Polyclonal antibody preparation
Host
Guinea pig
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
APC
Immunogen
n/a
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
500µg/mL
Organism Species More
n/a
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a cavia polyclonal antibody raised against CLU. It has been selected for its ability to recognize CLU in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
|
Magazine |
Citations |
|
Endocrinology |
Deficiency of Clusterin Exacerbates High-Fat Diet-Induced Insulin Resistance in Male Mice Pubmed: 24684302 |
|
J Mol Neurosci. |
Time-Dependent Decrease of Clusterin as a Potential Cerebrospinal Fluid Biomarker for Drug-Resistant Epilepsy. Pubmed: 24488574 |
|
PLOS ONE |
Serum Amyloid A and Clusterin as Potential Predictive Biomarkers for Severe Hand, Foot and Mouth Disease by 2D-DIGE Proteomics Analysis Pubmed:25268271 |
|
journal of immunological methods |
Proteomic analysis of human plasma and peripheral blood mononuclear cells in Systemic Lupus Erythematosus patients. pubmed:28390925 |
|
Journal of Alzheimer's Disease |
Proteomics Analysis of Blood Serums from Alzheimer's Disease Patients Using iTRAQ LabelingTechnology. pubmed:27911324 |
|
Biochimica Et Biophysica Acta |
Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells pubmed:28941799 |
|
World Neurosurgery |
Clusterin, a New Cerebrospinal Fluid Biomarker in Severe Subarachnoid Hemorrhage: A Pilot Study pubmed:28803177 |
|
BMC Cancer |
Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis Pubmed:29386009 |
|
Diabetes/metabolism research and reviews |
High serum clusterin levels are correlated with premature coronary artery disease in a Chinese population Pubmed: 30659732 |
|
Cancer Cell Int |
Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer 33602229 |
|
Catalog No. |
Related products for research use of Oryctolagus cuniculus (Rabbit) Organism species |
Applications (RESEARCH USE ONLY!) |
|
RPB180Rb01 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
|
PAB180Rb01 |
WB; IHC; ICC; IP. |
|
|
PAB180Rb51 |
WB; IHC; ICC; IP. |
|
|
LAB180Rb71 |
WB; IHC; ICC. |
|
|
LAB180Rb81 |
WB; IHC; ICC; IF. |
|
|
MAB180Rb22 |
WB; IHC; ICC; IP. |
|
|
MAB180Rb23 |
WB; IHC; ICC; IP. |
|
|
MAB180Rb24 |
WB; IHC; ICC; IP. |
|
|
MAB180Rb21 |
WB; IHC; ICC; IP. |
Share
